A detailed history of Caprock Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Caprock Group, Inc. holds 31,240 shares of VTRS stock, worth $334,892. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,240
Previous 53,454 41.56%
Holding current value
$334,892
Previous $465,000 33.55%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$8.74 - $10.69 $194,150 - $237,467
-22,214 Reduced 41.56%
31,240 $309,000
Q1 2025

May 15, 2025

SELL
$8.68 - $12.42 $358,510 - $512,983
-41,303 Reduced 43.59%
53,454 $465,000
Q4 2024

Jan 23, 2025

BUY
$11.32 - $13.37 $51,641 - $60,993
4,562 Added 5.06%
94,757 $1.18 Million
Q3 2024

Nov 07, 2024

SELL
$10.32 - $12.13 $31,682 - $37,239
-3,070 Reduced 3.29%
90,195 $1.05 Million
Q2 2024

Aug 06, 2024

BUY
$10.05 - $12.02 $937,313 - $1.12 Million
93,265 New
93,265 $991,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.